Navigation Links
NASA MidSTAR-1 successful technologies may be revolutionary
Date:2/19/2008

could find its way into homeland security applications such as explosives trace detectors.

The NCSU also can be used to measure nitrogen dioxide levels in the upper atmosphere. "If you had a sensor like this, the size of a postage stamp, you could lick and stick it to monitor chemicals and environmental constituents anywhere," Powell said. "NASA wants to put this in the International Space Station to monitor contaminants, and the Federal Aviation Administration may build hand-held NCSU systems so aircraft crews could detect explosives and/or harmful gases in aircraft," Powell said.

A relatively cheap integrated NCSU system capable of being stuck to any surface would have a wireless radio transmitter, ad-hoc network, and tiny solar cell or battery power supply about the size of a quarter. It could monitor environments and relay detection data for months or years before a replacement would be needed.

Since MidSTAR-1 was launched in March 2007, the sensor has been improved and can now detect and identify more than 15 different chemicals, including ammonia, hydrogen peroxide, hydrogen chloride, and formaldehyde.

Second-generation NCSUs being developed for the space station are capable of selectively sensing several chemical compounds simultaneously and may be hardwired to a permanent power- and data-transmission system for continuous, long-term monitoring of a wide array of environments.

Whether wireless or hard-wired, the systems could relay environmental status, contamination or threat data from multiple sites to centralized monitoring-stations located just about anywhere in the world, including to and from spacecraft and orbiting satellites.

The second successful revolutionary experiment on MidSTAR-1 is a variable emissivity film. The flight onboard MidSTAR-1 demonstrated how a special film, no thicker than an empty plastic sandwich bag, can control the temperature on a spacecraft. The technology had not be
'/>"/>

Contact: Rob Gutro
Robert.J.Gutro@nasa.gov
301-286-4044
NASA/Goddard Space Flight Center
Source:Eurekalert  

Page: 1 2 3 4

Related biology technology :

1. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
2. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
3. Phase I Safety and Tolerability Study With EVT 302 Successfully Completed
4. Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc
5. Laser Therapy Gives Smokers Hope for Successful New Years Resolution
6. Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results
7. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
8. James Webb Space Telescope marks successful completion
9. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
10. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
11. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NASA MidSTAR-1 successful technologies may be revolutionary
NASA MidSTAR-1 successful technologies may be revolutionary
(Date:11/6/2009)...Newswire-FirstCall/ - Microbix Biosystems Inc. (th...the Form 52-109F1 Certification of Annual Filings ... James Long, the Chief Financial Officer (the "Off...nnection with the annual audited financial stateme...he Company initially filed the annual financial st...
(Date:11/6/2009)..., November 6 EUCODIS Bioscience, a...nd marketing enzymes for the,chemical industry ann...greement with Bio Sidus, the leading biopharmaceut...ement gives EUCODIS Bioscience exclusive access - ...us, proprietary collection of,psychrophilic bacter...
(Date:11/6/2009)...v. 6 Intarcia Therapeutics, Inc. d...DUROS® continuous delivery of exenatide) prog...nth Annual Diabetes Technology Meeting in San Fran...i-bin/prnh/20050301/SFTU126LOGO ) ,, Continuo... Lowers Plasma Glucose, HbA1c and Reduces Weight i...
(Date:11/5/2009)...Nov. 5 The endangered black-footed...U.S. This rare carnivore feeds on prairie dogs. ...nd often entire population die-offs in towns occur...implemented a ferret breeding program and has been...merly native habitat. Unfortunately, plague can s...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
...ped innovative process is making waves in the nano...ew companies in the process. A new company based i...dard Space Flight Center,s unique single-walled ca...ns to make high-quality, low-cost SWCNTs available...ology are vast and include medical, construction, ...
...an Coulter,Inc. (NYSE: BEC ), a leading developer...lify, automate, and innovate complex biomedical te...Coulter,s president and chief,executive officer, w...nference on Tuesday, September 11, 2007, at 11:00 ...n/prnh/20031202/BECLOGO ) The live webcast of Bec...
...se of Business Today - VGNI Stock ... 4 Viragen,International, Inc. (OTC Bulletin Boar...Inc. (OTC Bulletin Board: VRAI), today announced t...its issued and outstanding common stock,will becom...ber 4, 2007. The reverse stock split was first an...
Other Biology Technology:NASA technology forms the basis for a new nanotechnology company 2Beckman Coulter to Present at the Bear Stearns Healthcare Conference 2Viragen International to Reverse Split Its Common Stock 2Viragen International to Reverse Split Its Common Stock 3
(Date:11/4/2009)...FirstCall/ -- Aware, Inc. (Nasdaq: AWRE ), a lead...s software, today reported financial results for i..., Michael Tzannes, Aware,s Chairman and Chief Exec...an agreement to sell our DSL and home networking p...r company being spun out of Infineon. This transa...
(Date:11/4/2009)...tCall/ -- BIO-key International, Inc. (OTC Bulleti... identification software is showcasing donor and p...nce being held at the New Orleans Convention Cente...nds-on product demonstrations of its state-of-the-... at 5 PM on Monday, October 26, Peter Lux, manager...
(Date:11/4/2009).../ -- GenVault Corporation (Carlsbad, CA) today ann... its Board of Directors. Dr. Brody, the Irwin Jac...n acclaimed physician-scientist and university lea...dy served as president of The Johns Hopkins Univer...ngineering and the Institute of Medicine, and is r...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7BIO-key(R) International Exhibiting at AABB TXPO 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia 48374 1Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia 48374 2Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia 48374 3Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia 48374 4DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 48372 1DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 48372 2DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 48372 3The secret of a snakes slither 8777 1
...s vaginalis colonises the urogenital tract and cau...common non-viral STI. , University of Queensland P...cientists that worked on the project to sequence t...ments for both men and women. , Ms Dunne said t...enes and gene families of interest, particularly t...
...t study to date of genetic variation among chimpan...ed sorting of chimps into three populations—wester...nt genetic differences, two to three times greater...an populations. , In the April 2007 issue of the ...sity of Chicago, Harvard, the Broad Institute and ...
...C. von Borstel, cancer is a metaphorical example o...the first pregnant finch that landed on a deserted...ncer cell in the human body has to undergo many mu...lf as an invader of different organs in the body. ...ecies in different ecological niches, cancer is to...
Other Biology News:Scientists perform 'tricky' operation 2Gene study shows three distinct groups of chimpanzees 2Cancer that colonizes our bodies 2
ICC Diluent Buffer from BD Biosciences Pharmingen
Anti-J Chain Monoclonal Antibody, Unconjugated, Clone M19/9J from CHEMICON
ZOOM® IEF Fractionator from Invitrogen
Tissue Stat from Biomeda Corporation
Biology Products: